ST. LOUIS, Aug. 6, 2026 /PRNewswire/ — Global automation leader Emerson (NYSE: EMR) today announced it has acquired Glue Inc., an innovator in advancing intelligent validation and test through its AI-enabled software product Glue Studio. Glue Studio features specialized AI-centric capabilities for test generation and planning. The acquisition strengthens Emerson’s strategy to deliver more software-defined, data-centric capabilities across Test & Measurement’s NI portfolio.
Glue Studio’s technology accelerates the continued investment in Emerson’s NI Nigel™ AI, the industry’s first AI specifically optimized for test and measurement workflows. Nigel reflects Emerson’s vision for AI in test and measurement: domain-specific, deeply integrated, and designed to improve human decision-making. Nigel is embedded directly within NI software and trained in test system design, methodologies and data analysis, providing context-aware guidance throughout product development. As a result, Nigel delivers productivity improvements including faster product releases and increased customer engagement. Glue Studio’s capabilities will strengthen Nigel’s ability to connect validation workflows, enhance traceability and accelerate the path from design to verified performance.
“Glue Studio brings highly complementary capabilities that align closely with Emerson’s strategy to lead in software-defined test and measurement,” said Ritu Favre, Group President of Test & Measurement at Emerson. “By integrating Glue Studio’s AI-enabled validation technology into Nigel, we are enhancing our ability to extend AI-assisted test planning and validation across the engineering workflow and help customers improve engineering decisions.”
For more information on NI Nigel™ AI, visit: Explore NI Nigel AI.
Terms of the transaction were not disclosed.
About Emerson
Emerson (NYSE: EMR) is a global automation leader delivering solutions for the most demanding technology challenges. Headquartered in St. Louis, Missouri, Emerson is engineering the autonomous future, enabling customers to optimize operations and accelerate innovation. For more information, visit Emerson.com.
Forward-Looking and Cautionary Statements
Statements in this press release that are not strictly historical may be “forward-looking” statements, which represent management’s expectations, based on currently available information. Actual results, performance or achievements could differ materially from those expressed in any forward-looking statement. Any forward-looking statements in this press release speak only as of the date of this press release. Emerson undertakes no obligation to update any such statements to reflect new information or later developments. Examples of risks and uncertainties that may cause our actual results or performance to be materially different from those expressed or implied by forward looking statements include the scope, duration and ultimate impacts of the Russia-Ukraine, Middle East and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company’s most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company’s expectation for its consolidated results, other than as noted herein.
Emerson uses our Investor Relations website, https://ir.emerson.com/, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
Contacts
Investors
Doug Ashby
(314) 553-2197
Media
Joseph Sala / Greg Klassen / Connor Murphy
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449
